The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Endogenous TNFα Lowers Maximum Peak Bone Mass and Inhibits Osteoblastic Smad Activation Through NF-κB
Abstract
Endogenous TNFα prevents the attainment of maximum achievable peak bone mass in vivo. In vitro, TNFα suppresses BMP-2– and TGFβ-mediated Smad activation through induction of NF-κB. Consistently, pharmacological suppression of NF-κB augments osteoblast differentiation and mineralization in vitro. Introduction: Osteoporosis is a major health threat. Traditional therapeutic strategies have centered on anti-catabolic drugs that block bone resorption. Recently focus has shifted to anabolic agents that actively rebuild lost bone mass. Future strategies may involve elevating peak bone mass to delay osteoporosis development. Recent in vitro studies show that TNFα represses osteoblast differentiation and mineralization; however, the mechanisms are poorly understood and the impact of basal TNFα concentrations on the acquisition of peak bone mass in vivo is unknown. Materials and Methods: We examined peak BMD, bone volume, and bone turnover makers in mice deficient in TNFα or its receptors. We further examined the effect of TNFα on Smad-induced signaling by TGFβ and BMP-2 in vitro using a Smad responsive reporter. The effect of TNFα-induced NF-κB signaling on Smad signaling and on in vitro osteoblast mineralization was examined using specific NF-κB inhibitors and activators, and effects of TNFα-induced NF-κB signaling on BMP-2–induced Runx2 mRNA were examined using RT-PCR. Results: Mice null for TNFα or its p55 receptor had significantly increased peak bone mass, resulting exclusively from elevated bone formation. In vitro, TNFα potently suppressed Smad signaling induced by TGFβ and BMP-2, downregulated BMP-2–mediated Runx2 expression, and inhibited mineralization of osteoblasts. These effects were mimicked by overexpression of NF-κB and prevented by pharmacological NF-κB suppression. Conclusions: Our data suggest that TNFα and NF-κB antagonists may represent novel anabolic agents for the maximization of peak basal bone mass and/or the amelioration of pathological bone loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α
Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11066 · Cited by 705
Self-citationOsteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.793 · Cited by 578 · cited 1×
“High doses of TNF have been reported to induce apoptosis of human OBs treated with 1,25(OH)2D3 (38) and in MC3T3-E1 pre-osteoblastic cells.((39)) However, in line with other reports,((8)) we found that TNF did not stimulate apoptosis of MC3T3 cells at”
ResultInhibition of Osteoblast Differentiation by Tumor Necrosis Factor-α*
Gilbert, L., He, X., Farmer, P., Boden, S., Kozlowski, M., Rubin, J., & Nanes, M. S. (2000) · Endocrinology · doi:10.1210/endo.141.11.7739 · Cited by 555
Self-citationRoggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G., & Pacifici, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251534698 · Cited by 513
Self-citationNF-κB as a therapeutic target in chronic inflammation: recent advances
Makarov, S. S. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01814-1 · Cited by 379
Redlich, K., Görtz, B., Hayer, S., Zwerina, J., Doerr, N., Kostenuik, P., Bergmeister, H., Kollias, G., Steiner, G., Smolen, J. S., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63144-6 · Cited by 134
Cited by
TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation
Rahman, M. S., Akhtar, N., Jamil, H. M., Banik, R. S., & Asaduzzaman, S. M. (2015) · Bone Research · doi:10.1038/boneres.2015.5 · Cited by 587
Novack, D. V. (2011) · Cell Research · doi:10.1038/cr.2010.159 · Cited by 315
Almeida, M., Han, L., Ambrogini, E., Weinstein, R. S., & Manolagas, S. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.283481 · Cited by 270
Beck, G. R., Ha, S.-W., Camalier, C. E., Yamaguchi, M., Li, Y., Lee, J.-K., & Weitzmann, M. N. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.11.003 · Cited by 267
Self-citationWeitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 259
Self-citation
Metadata
- Authors
- Li, Y., Li, A., Strait, K., Zhang, H., Nanes, M. S., & Weitzmann, M. N.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-01
- Volume
- 22
- Issue
- 5
- Pages
- 646-655
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2006385099
- Cited by
- 181
- References
- 6
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endogenous TNFα Lowers Maximum Peak Bone Mass and Inhibits Osteoblastic Smad Activation Through NF-κB. https://app.cochat.ai/papers/10.1359/jbmr.070121
- The paper
- Li, Y., Li, A., Strait, K., Zhang, H., Nanes, M. S., & Weitzmann, M. N. (2007). Endogenous TNFα Lowers Maximum Peak Bone Mass and Inhibits Osteoblastic Smad Activation Through NF-κB. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.070121
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.